that proves even the BB's can make a mistake. LJPC is a junk stock, always has been. Maybe they know something, but it's not for me and my money. In fact, I will take a look into the puts!
I don't recall Cramer mentioning the stock until it was much higher, but I have only been an owner since a few months before the massive rise started. I learned about ACAD from an outstanding ARNA poster who pointed out the similarities in the research targets between the companies. He actually thought ARNA might buy ACAD because of their research similarities, but ACAD needs a marketing partner and Eiasi is ARNA's marketing partner, so I don't see the need to merge. I did my own research and risked my own capital, but a big assist came from Sauve9 on the ARNA MB.
looks to me like nothing but air between here and $16.5. If someone is looking to enter, I think I would wait for at least that entry point. So far, buying IMGN after any rally has not worked out and selling calls into any rally has. One day, without any notice, that could change, but I don't get a sense that one day will happen any time in 2014. Anyway, that my thinking and my trading strategy (around my core long stock position) reflects it.
still in since the $2's, but with some covered call losses/rebuys. I am short the Jan 2015 $40's and starting to worry about those now. Will probably wait for more evidence that approval is in the bag before I extend those up again. 52-week high is in sight!
you might want to consider selling the $26 puts if you want to own at or below $26. You can get $1.1 for selling the March puts now, more for the later dates. FYI, not advice. Put sales are not for everyone.
my point is, the 2 major biotech blunders I made were GNTA and CELG. Both failed in advanced phase III testing after very small phase II trials that were poorly designed. Before I get involved, I like to see evidence from a decent size, well designed and controlled human clinical trial. Prefer double-blind measured against placebo or even better, the current standard of care. Just IMO, not advice. I see insiders have been buying and that's a positive sign and very unusual for development stage biotech execs. Most bio-execs award themselves a ton of free shares, dilute shareholders and then sell them.
Based on the number of ignored posts and the few that were not ignored, it appears shorts are in a panic and should buy calls, sell puts and abandon their shorts ASAP, but not in public please.
Does SNTA have any strong phase II data with a reasonable pt sample size?
should they really be studying patients with known cardio disease? I assume all obses patients have the risk factors. I thought they were avoiding people with cardio disease. Seems like asking for trouble.
sold a ton of higher price calls between Friday and this morning and bought back my higher strike short puts this morning. I am ready for the Immunoflopogen again. I don't trust any rally's in this stock. If it goes to $20+ I am ready to say thanks and move on.
ADP is just getting started, 3 is 1-2 years away. Several heavily shorted, high potential biotech's were up big today. I think it was get shorty day. I had to buy back some March 29 calls I sold against the stock and move out to the Jan 40. I think that if it reaches $40 I will just let it go, but who knows, I may end up buying those back also unless there's an acquisition.
Powerful bio-pharma rally underway. ACAD is flying!
maybe, ACAD is also flying. IMGN is only my 2nd best performer today. Maybe shorts are being called in on some stocks. If so, keep an eye on ARNA, it's one of the most heavily shorted/manipulated. This is some move!
sounds about right. Sold some calls here, probably helping to fuel the rally. Very unexpected on decent volume, must be an upgrade, or some news only known to institutions. DJ just sold some shares, so apparently he was not aware either. Nice to see a break out! Now I can spend more time on my day job and stop complaining until the offering or the good thing that is unknown is announced. WOW, major break out!
How is this early, the quarter ended about 7 weeks ago? We are more than half way through Q1 and will be almost 2/3 by then.